Arkolith/Insider Trading/LAB/Form 4

Egholm Michael

President & CEO, DirectorSTANDARD BIOTOOLS INC. (LAB) · full profile →Form 4 · filed May 22, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 21, 2025Sell(S)5K$1.03$5K2.8M
May 20, 2025Tax withholding(F)18K$1.05$19K2.8M

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-076591) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML